BioCorRx Inc.
BICX
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.97M
Close$
Share Statistics
| Market cap | $5.97 Million |
|---|---|
| Enterprise Value | $13.61 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.19 |
| Beta | 0.22 |
| Outstanding Shares | 29,219,541 |
Return
| Return on Equity | 25.86% |
|---|---|
| Return on Assets | -165.73% |
| Return on Invested Capital | 47.67% |
Valuation & Multiples
| P/E Ratio | -1.78 |
|---|---|
| PEG | 8.15 |
| Price to Sales | - |
| Price to Book Ratio | -0.23 |
| Enterprise Value to Revenue | 17.3 |
| Enterprise Value to EBIT | -4.11 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.56 |
| Debt to Equity | -0.63 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
$-0.05
Average shareholder expectationRevenue Estimate
$240,000
Average shareholder expectationNext Earnings Call
Expected Date
November 17, 2026
EPS Estimate
$-0.05
Average shareholder expectationRevenue Estimate
$250,000
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About BioCorRx Inc.
3 employees
CEO: Lourdes Felix BioCorRx Inc. (BICX), through its various operations, is dedicated to creating and delivering therapeutic solutions for individuals struggling with substance dependence and related health conditions across the United States. Among its co...